Cargando…
The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells
Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance, brain tumors such as glioblastoma, the most common and aggressive brain tumor. To utilize the fa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227832/ https://www.ncbi.nlm.nih.gov/pubmed/35745698 http://dx.doi.org/10.3390/pharmaceutics14061125 |
_version_ | 1784734280290664448 |
---|---|
author | Rustad, Eirik A. L. von Hofsten, Susannah Kumar, Robin Lænsman, Eirik A. Berge, Gerd Škalko-Basnet, Nataša |
author_facet | Rustad, Eirik A. L. von Hofsten, Susannah Kumar, Robin Lænsman, Eirik A. Berge, Gerd Škalko-Basnet, Nataša |
author_sort | Rustad, Eirik A. L. |
collection | PubMed |
description | Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance, brain tumors such as glioblastoma, the most common and aggressive brain tumor. To utilize the fact that such tumors are characterized by an acidic extracellular environment, we selected pH-responsive liposomes as a potential drug delivery system for superior delivery to GBM. Liposomes comprising PEGylated lipid of two chain lengths with encapsulated fluorescent marker calcein were characterized and challenged against non-PEGylated vesicles. The in vitro calcein release from three liposomal formulations (<200 nm), namely non-PEGylated (pH-Lip) and PEGylated, pH-Lip–PEG750, and pH-Lip–PEG2000, was followed at three pH conditions to prove the pH-responsiveness. The intracellular delivery of a liposomally encapsulated marker was determined in GL261 glioblastoma cell lines in vitro using both flow cytometry and confocal microscopy. The inclusion of PEG2000 within liposomal formulation resulted in reduced in vitro pH-responsiveness compared to pH-Lip and pH-Lip750. All three pH-responsive liposomal formulations improved intracellular uptake in GL261 cells compared to non-pH-responsive liposomes, with negligible differences regarding PEG length. The proposed formulations should be further evaluated in glioblastoma models. |
format | Online Article Text |
id | pubmed-9227832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92278322022-06-25 The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells Rustad, Eirik A. L. von Hofsten, Susannah Kumar, Robin Lænsman, Eirik A. Berge, Gerd Škalko-Basnet, Nataša Pharmaceutics Article Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance, brain tumors such as glioblastoma, the most common and aggressive brain tumor. To utilize the fact that such tumors are characterized by an acidic extracellular environment, we selected pH-responsive liposomes as a potential drug delivery system for superior delivery to GBM. Liposomes comprising PEGylated lipid of two chain lengths with encapsulated fluorescent marker calcein were characterized and challenged against non-PEGylated vesicles. The in vitro calcein release from three liposomal formulations (<200 nm), namely non-PEGylated (pH-Lip) and PEGylated, pH-Lip–PEG750, and pH-Lip–PEG2000, was followed at three pH conditions to prove the pH-responsiveness. The intracellular delivery of a liposomally encapsulated marker was determined in GL261 glioblastoma cell lines in vitro using both flow cytometry and confocal microscopy. The inclusion of PEG2000 within liposomal formulation resulted in reduced in vitro pH-responsiveness compared to pH-Lip and pH-Lip750. All three pH-responsive liposomal formulations improved intracellular uptake in GL261 cells compared to non-pH-responsive liposomes, with negligible differences regarding PEG length. The proposed formulations should be further evaluated in glioblastoma models. MDPI 2022-05-25 /pmc/articles/PMC9227832/ /pubmed/35745698 http://dx.doi.org/10.3390/pharmaceutics14061125 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rustad, Eirik A. L. von Hofsten, Susannah Kumar, Robin Lænsman, Eirik A. Berge, Gerd Škalko-Basnet, Nataša The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title | The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title_full | The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title_fullStr | The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title_full_unstemmed | The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title_short | The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells |
title_sort | ph-responsive liposomes—the effect of pegylation on release kinetics and cellular uptake in glioblastoma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227832/ https://www.ncbi.nlm.nih.gov/pubmed/35745698 http://dx.doi.org/10.3390/pharmaceutics14061125 |
work_keys_str_mv | AT rustadeirikal thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT vonhofstensusannah thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT kumarrobin thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT lænsmaneirika thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT bergegerd thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT skalkobasnetnatasa thephresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT rustadeirikal phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT vonhofstensusannah phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT kumarrobin phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT lænsmaneirika phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT bergegerd phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells AT skalkobasnetnatasa phresponsiveliposomestheeffectofpegylationonreleasekineticsandcellularuptakeinglioblastomacells |